Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with insomnia ...

Insomnia affects millions and is closely linked to heart and mental health. Here's what we know about causes, treatments, and ...

People spend about a third of their lives asleep. Yet, surprisingly little is known about how our brains control falling ...

New Research Evaluating the Clinical, Economic and Humanistic Burden of Narcolepsy and Findings From ... downstream wake-promoting pathways that project widely throughout the brain.

Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38th annual meeting of the Associated Professional Sleep Societies (APSS), taking ...

Sleep disorders may lead to structural brain changes, cognitive decline, and neurological disease. Here’s what science says about the risk.

Findings suggest a potential therapeutic alternative to existing narcolepsy treatments without hepatotoxic effects associated with other treatment types. Narcolepsy type 1 is a neurological ...

Takeda today announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an ...

School can pose special challenges for children with narcolepsy. But your student can succeed with the right changes to their routine and support from their doctor, teachers, and school staff.